Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Aquila issued patent covering potent drug delivery agents

Aug. 8, 1997

Transkaryotic Therapies allowed European patent for gene therapy technology

Aug. 7, 1997

Patent for dry powder inhaler issued to TheraTech

Aug. 7, 1997

DiagnoCure granted U.S. patent for nanoerythrosomes

Aug. 7, 1997

Patent protection granted for Hybridon second- and third-generation oligonucleotides

Aug. 6, 1997

Tripos, Panlabs and Amylin reach metabolic drug screening agreement

Aug. 6, 1997

FDA gives AngioDynamics marketing clearance for its Pulse-Spray Injector

Aug. 6, 1997

CombiChem and Sumitomo establish drug discovery collaboration

Aug. 5, 1997

Access and The Dow Chemical Company enter into collaboration

Aug. 4, 1997

Stanford scientists report breakthrough in polyketide research

Aug. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...